The Bill & Melinda Gates Foundation announced today a commitment of up to $120 million to accelerate access to the investigational antiviral drug molnupiravir for lower-income countries as part of its COVID-19 response effort.
As part of the Generation Equality Forum convened by UN Women and co-hosted by the governments of Mexico and France, the Bill & Melinda Gates Foundation today announced a commitment of $2.1 billion over the next five years to advance women’s economic empowerment, strengthen women and girls’ health and family planning, and accelerate women’s leadership
